Scientific Review Concludes That Gingko Biloba Has Positive Benefits For The Elderly
A scientific review of 33 clinical research trials of Gingko Biloba in elderly populations has concluded that the herb has a positive impact on some of the symptoms of dementia. Dementia, which mainly effects aged populations, is defined as a deterioration of mental faculties. Some of the symptoms of dementia are memory loss, disruptions in concentration, emotional disturbances and dizziness. The comprehensive review was funded by the Alzheimer Society, a UK-based organization, and was conducted by the highly respected Cochrane Collaboration at Oxford University. The research that was analyzed spanned a 40-year period of time with the trials lasting anywhere from 3 to 52 weeks. Researchers did recommend further clinical trials of ginkgo because they noted a few problems with the structure of some of the early trials. In a statement made by John Cardellina, Ph.D., of the Council for Responsible Nutrition in the United States, "Gingko is among the top selling herbal supplements in the U.S. and, given the recent conflicting news reports about ginkgo's benefits, consumers will want to know more about the Cochrane Collaborations's findings. This analysis provides sufficient scientific support for consumers, particularly the elderly with early stage dementia or memory loss, to feel confident that ginkgo is a viable product for improving memory function." Source: www.npicenter.com. Read More.
A scientific review of 33 clinical research trials of Gingko Biloba in elderly populations has concluded that the herb has a positive impact on some of the symptoms of dementia. Dementia, which mainly effects aged populations, is defined as a deterioration of mental faculties. Some of the symptoms of dementia are memory loss, disruptions in concentration, emotional disturbances and dizziness. The comprehensive review was funded by the Alzheimer Society, a UK-based organization, and was conducted by the highly respected Cochrane Collaboration at Oxford University. The research that was analyzed spanned a 40-year period of time with the trials lasting anywhere from 3 to 52 weeks. Researchers did recommend further clinical trials of ginkgo because they noted a few problems with the structure of some of the early trials. In a statement made by John Cardellina, Ph.D., of the Council for Responsible Nutrition in the United States, "Gingko is among the top selling herbal supplements in the U.S. and, given the recent conflicting news reports about ginkgo's benefits, consumers will want to know more about the Cochrane Collaborations's findings. This analysis provides sufficient scientific support for consumers, particularly the elderly with early stage dementia or memory loss, to feel confident that ginkgo is a viable product for improving memory function." Source: www.npicenter.com. Read More.